1KX

{(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol

Find entries where: 1KX

is present as a standalone ligand in 4 entries

Find related ligands:

Chemical Component Summary
Name	{(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol
Synonyms	Abacavir
Identifiers	[(1S,4R)-4-[2-azanyl-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol
Formula	C₁₄ H₁₈ N₆ O
Molecular Weight	286.332
Type	NON-POLYMER
Isomeric SMILES	c1nc2c(nc(nc2n1[C@@H]3C[C@@H](C=C3)CO)N)NC4CC4
InChI	InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10+/m1/s1
InChIKey	MCGSCOLBFJQGHM-SCZZXKLOSA-N

Chemical Details
Formal Charge	0
Atom Count	39
Chiral Atom Count	2
Bond Count	42
Aromatic Bond Count	10

Drug Info: DrugBank

DrugBank ID	DB01048
Name	Abacavir
Groups	approved investigational
Description	Abacavir (ABC) is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. Chemically, it is a synthetic carbocyclic nucleoside and is the enantiomer with 1S, 4R absolute configuration on the cyclopentene ring. In vivo, abacavir sulfate dissociates to its free base, abacavir.
Synonyms	Abacavir sulfate Abacavir hydrochloride Abacavir hydrochloride monohydrate {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol ABC Abacavir
Brand Names	Mint-abacavir Apo-abacavir-lamivudine Epzicom Ziagen Apo-abacavir-lamivudine Tablets Teva-abacavir/lamivudine Trizivir PMS-abacavir-lamivudine Auro-abacavir/lamivudine Triumeq Abacavir and lamivudine Abacavir Sulfate Apo-abacavir-lamivudine-zidovudine Mylan-abacavir/lamivudine Triumeq PD Abacavir Abacavir Sulfate, Lamivudine and Zidovudine Jamp Abacavir / Lamivudine Abacavir, Lamivudine and Zidovudine Mint-abacavir/lamivudine Apo-abacavir Abacavir and Lamivudine Kivexa
Indication	Abacavir is indicated in combination with other anti-retroviral agents for the treatment of HIV-1 infection.[L30400] It is available in a combination product alongside [dolutegravir] and [lamivudine] for the treatment of adult and pediatric patients with HIV-1 who weigh ≥10 kg.[L41365]
Categories	Anti-HIV Agents Anti-Infective Agents Anti-Retroviral Agents Antiinfectives for Systemic Use Antiviral Agents Antivirals for Systemic Use Antivirals used in combination for the treatment of HIV infections Cycloparaffins Deoxyadenosines Deoxyribonucleosides Dideoxynucleosides Direct Acting Antivirals Drugs that are Mainly Renally Excreted Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor Nucleic Acid Synthesis Inhibitors Nucleic Acids, Nucleotides, and Nucleosides Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Nucleoside Reverse Transcriptase Inhibitors Nucleosides Purine Nucleosides Purines Reverse Transcriptase Inhibitors UGT1A1 Substrates
ATC-Code	J05AR13 J05AR02 J05AR04 J05AF06
CAS number	136470-78-5

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Reverse transcriptase/RNaseH	PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKI...	unknown	inhibitor
HLA class I histocompatibility antigen, B-57 alpha chain	MRVTAPRTLLLLLWGAVALTETWAGSHSMRYFHTSVSRPGRGEPRFITVG...	unknown
Adenosine kinase	MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVDKDFLDKYSL...	unknown	substrate
Alcohol dehydrogenase 6	MCTTGQVIRCKAAILWKPGAPFSIEEVEVAPPKAKEVRIKVVATGLCGTE...	unknown	substrate
UDP-glucuronosyltransferase 1-1	MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQL...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682